Reliance Infrastructure, Afcons and Narayana Hrudayalaya will be among 202 companies to post earnings reports for the January ...

The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...

Mid Cap Specialty chemical stock gained more than 8% during the intraday trades on Friday post Q4 results and Dividend ...

Amid a backdrop of easing trade tensions between the U.S. and China, global markets have experienced a notable rally, with ...

With the Mumbai-based ... its biggest market for pharmaceutical products manufactured in India, including generic or off-patent drugs and pricier branded products. Indian pharma companies will ...

Deven Choksey suggests a protective portfolio strategy, favoring large-cap companies amidst market enthusiasm for mid and ...

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData. BMS had the ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...

Some of the most exciting new drugs are being discovered by mid-sized pharma and biotech ... analysed a group of 35 mid-cap companies, most of which are based in the US, but does include European ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., where tariff threats have ...

Amid market resilience, Deven Choksey anticipates Nifty potentially reaching 25,200, with corrections offering buying ...

Sudarshan Pharma Industries Limited's board has resolved on May 13, 2025, to acquire 300 shares of Cibachem General Trading L ...